Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627339 · ClinicalTrials.gov registry record
Building a Database of Results From People Without Eye Problems
A clinical trial, sponsored by Wills Eye.
- Completed
- Registry status
- 208
- Enrollment target
NCT02627339 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 208 participants.
The verdict
NCT02627339 has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
The purpose of this study is to build a database of results from a new test that measures contrast sensitivity (the Spaeth-Richman Contrast Sensitivity Test (SPARCS)). Contrast sensitivity is an important part of your ability to see. When contrast sensitivity decreases, you are less able to see objects and detect motion. For instance, if you have decreased contrast sensitivity, you might be less able to read, see in the dark, drive, hit a ball, or walk safely. Decrease in contrast sensitivity leads to a decrease in quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02627339
The ClinicalTrials.gov registry entry for NCT02627339 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02627339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02627339 about?
NCT02627339 is a clinical study titled "Building a Database of Results From People Without Eye Problems". The purpose of this study is to build a database of results from a new test that measures contrast sensitivity (the Spaeth-Richman Contrast Sensitivity Test (SPARCS)). Contrast sensitivity is an important part of your ability to see. When contrast sensitivity decreases, you are less able to see obje...
What is the current status of trial NCT02627339?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2012-08. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02627339?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.